SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases

References

• Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020;8(8):816–821. doi:10.1016/S2213-2600(20)30304-0
   PubMed Web of Science ®Google Scholar
• COVID-19 data portal, Center for Systems Science and Engineering, The Johns Hopkins University, Baltimore MD USA. Available from: https://coronavirus.jhu.edu/. Accessed October 01, 2021.
   Google Scholar
• Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty. 2020;9(1):45. doi:10.1186/s40249-020-00662-x
   PubMed Web of Science ®Google Scholar
• Narayan SS, Lorenz K, Ukkat J, Hoang-Vu C, Trojanowicz B. Angiotensin converting enzymes ACE and ACE2 in thyroid cancer progression. Neoplasma. 2020;67(2):402–409. doi:10.4149/neo_2019_190506N405
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi:10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875–879. doi:10.1038/nm1267
   PubMed Web of Science ®Google Scholar
• Tipnis SR, Hooper NM, Hyde R, Karran E, Christie, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275(43):33238–33243. doi:10.1074/jbc.M002615200
   PubMed Web of Science ®Google Scholar
• Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87(5):E1–9. doi:10.1161/01.res.87.5.e1
   PubMed Web of Science ®Google Scholar
• Hamming I, Cooper ME, Haagmans BL, et al. The emerging role of ACE2 in physiology and disease. J Pathol. 2007;212(1):1–11. doi:10.1002/path.2162
   PubMed Web of Science ®Google Scholar
• Vickers C, Hales P, Kaushik V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277(17):14838–14843. doi:10.1074/jbc.M200581200
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181(2):281–292.e6. doi:10.1016/j.cell.2020.02.058
   PubMed Web of Science ®Google Scholar
• Chi M, Shi X, Huo X, Wu X, Zhang P, Wang G. Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2. Ann Transl Med. 2020;8(8):531. doi:10.21037/atm.2020.04.28
   PubMed Web of Science ®Google Scholar
• Glowacka I, Bertram S, Muller MA, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol. 2011;85(9):4122–4134. doi:10.1128/JVI.02232-10
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271–280.e8. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of sars-cov-2 is essential for infection of human lung cells. Mol Cell. 2020;78(4):779–784.e5. doi:10.1016/j.molcel.2020.04.022
   PubMed Web of Science ®Google Scholar
• Daly JL, Simonetti B, Klein K, et al. Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. 2020;370(6518):861–865. doi:10.1126/science.abd3072
   PubMed Web of Science ®Google Scholar
• Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370(6518):856–860. doi:10.1126/science.abd2985
   PubMed Web of Science ®Google Scholar
• Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Hussain M, Jabeen N, Raza F, et al. Structural Variations in Human ACE2 may Influence its Binding with SARS-CoV-2 Spike Protein. J Med Virol. 2020;92(9):1580–1586. doi:10.1002/jmv.25832
   PubMed Web of Science ®Google Scholar
• Epelman S, Tang WHW, Chen SY, Van Lente F, Francis GS, Sen S. Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System. J Am Coll Cardiol. 2008;52(9):750–754. doi:10.1016/j.jacc.2008.02.088
   PubMed Web of Science ®Google Scholar
• Bouhaddou M, Memon D, Meyer B, et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020;182(3):685–712.e19. doi:10.1016/j.cell.2020.06.034
   PubMed Web of Science ®Google Scholar
• Klann K, Bojkova D, Tascher G, Ciesek S, Münch C, Cinatl J. Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication. Mol Cell. 2020;80(1):164–174.e4. doi:10.1016/j.molcel.2020.08.006
   PubMed Web of Science ®Google Scholar
• Bojkova D, Klann K, Koch B, et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature. 2020;583(7816):469–472. doi:10.1038/s41586-020-2332-7
   PubMed Web of Science ®Google Scholar
• Facchiano A, Facchiano F, Facchiano A. An investigation into the molecular basis of cancer comorbidities in coronavirus infection. FEBS Open Bio. 2020;10(11):2363–2374. doi:10.1002/2211-5463.12984
   PubMed Web of Science ®Google Scholar
• Giovanella L, Ruggeri RM, Ovčariček PP, Campenni A, Treglia G, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021;1–8. doi:10.1007/s40336-021-00419-y
   Web of Science ®Google Scholar
• Lui DTW, Lee CH, Chow WS, et al. Thyroid Dysfunction in Relation to Immune Profile, Disease Status and Outcome in 191 Patients with COVID-19. J Clin Endocrinol Metab. 2021;106(2):e926–e935. doi:10.1210/clinem/dgaa813
   PubMed Web of Science ®Google Scholar
• Lui DTW, Lee CH, Chow WS, et al. Insights from a Prospective Follow-up of Thyroid Function and Autoimmunity among COVID-19 Survivors. Endocrinol Metab. 2021;36(3):582–589. doi:10.3803/EnM.2021.983
   Google Scholar
• Poma AM, Bonuccelli D, Giannini R, et al. COVID-19 autopsy cases: detection of virus in endocrine tissues. J Endocrinol Invest. 2021:1–6. doi:10.1007/s40618-021-01628-y
   Web of Science ®Google Scholar
• Ferrara JL. Cytokine dysregulation as a mechanism of graft versus host disease. Curr Opin Immunol. 1993;5(5):794–799. doi:10.1016/0952-7915(93)90139-j
   PubMed Web of Science ®Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474. doi:10.1126/science.abb8925
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi:10.1016/S2213-2600(20)30076-X
   PubMed Web of Science ®Google Scholar
• Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383(25):2451–2460. doi:10.1056/NEJMcp2009575
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Yatim N, Barnabei L, et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science. 2020;369(6504):718–724. doi:10.1126/science.abc6027
   PubMed Web of Science ®Google Scholar
• Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32. doi:10.1016/j.cytogfr.2020.05.003
   PubMed Web of Science ®Google Scholar
• Croce L, Gangemi D, Ancona G, et al. The cytokine storm and thyroid hormone changes in COVID-19. J Endocrinol Invest. 2021;44(5):891–904. doi:10.1007/s40618-021-01506-7
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20(6):355–362. doi:10.1038/s41577-020-0331-4
   PubMed Web of Science ®Google Scholar
• Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 Cytokine Storm; What We Know So Far. Front Immunol. 2020;11:1446. doi:10.3389/fimmu.2020.01446
   PubMed Web of Science ®Google Scholar
• Hue S, Beldi-Ferchiou A, Bendib I, et al. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;202(11):1509–1519. doi:10.1164/rccm.202005-1885OC
   PubMed Web of Science ®Google Scholar
• De Biasi S, Meschiari M, Gibellini L, et al. Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun. 2020;11(1):3434. doi:10.1038/s41467-020-17292-4
   PubMed Web of Science ®Google Scholar
• Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine Storm in COVID-19: the Current Evidence and Treatment Strategies. Front Immunol. 2020;11:1708. doi:10.3389/fimmu.2020.01708
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Giuffrida G, Campennì A. Autoimmune endocrine diseases. Minerva Endocrinol. 2018;43(3):305–322. doi:10.23736/S0391-1977.17.02757-2
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Campennì A, Deandreis D, et al. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol. 2021;17(7):737–759. doi:10.1080/1744666X.2021
   PubMed Web of Science ®Google Scholar
• Minciullo PL, Ruggeri RM, Vita G, Benvenga S, Gangemi S. Development of Hashimoto’s thyroiditis after subacute thyroiditis: an unusual patient. Thyroid. 2009;19(1):73–74. doi:10.1089/thy.2008.0234
   PubMed Web of Science ®Google Scholar
• Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62–75. doi:10.1016/j.cytogfr.2020.06.001
   PubMed Web of Science ®Google Scholar
• Morshed SA, Latif R, Davies TF. Delineating the autoimmune mechanisms in Graves’ disease. Immunol Res. 2012;54(1–3):191–203. doi:10.1007/s12026-012-8312-8
   PubMed Web of Science ®Google Scholar
• Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 2009;19(5):495–501. doi:10.1089/thy.2008.0423
   PubMed Web of Science ®Google Scholar
• Shi Y, Wang H, Su Z, et al. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto’s thyroiditis. Scand J Immunol. 2010;72(3):250–255. doi:10.1111/j.1365-3083.2010.02425.x
   PubMed Web of Science ®Google Scholar
• Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953–962. doi:10.1210/jc.2009-1719
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Saitta S, Cristani M, et al. Serum interleukin-23 (IL-23) is increased in Hashimoto’s thyroiditis. Endocr J. 2014;61(4):359–363. doi:10.1507/endocrj.ej13-0484
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Minciullo P, Saitta S, et al. Serum interleukin-22 (IL-22) is increased in the early stage of Hashimoto’s thyroiditis compared to non-autoimmune thyroid disease and healthy controls. Hormones. 2014;13(3):338–344. doi:10.14310/horm.2002.1483
   PubMedGoogle Scholar
• Vitales-Noyola M, Ramos-Levi AM, Martínez-Hernández R, et al. Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine. 2017;57(3):409–417. doi:10.1007/s12020-017-1361-y
   PubMed Web of Science ®Google Scholar
• Kristensen B, Hegedüs L, Madsen HO, Smith TJ, Nielsen CH. Altered balance between self-reactive T helper (Th)17 cells and Th10 cells and between full-length forkhead box protein 3 (FoxP3) and FoxP3 splice variants in Hashimoto’s thyroiditis. Clin Exp Immunol. 2015;180(1):58–69. doi:10.1111/cei.12557
   PubMed Web of Science ®Google Scholar
• Li Q, Wang B, Mu K, Zhang JA. The pathogenesis of thyroid autoimmune diseases: new T lymphocytes—cytokines circuits beyond the Th1−Th2 paradigm. J Cell Physiol. 2019;234(3):2204–2216. doi:10.1002/jcp.27180
   PubMed Web of Science ®Google Scholar
• Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148(1):32–46. doi:10.1111/j.1365-2249.2007.03356.x
   PubMed Web of Science ®Google Scholar
• Giovanella L, Ruggeri RM, Petranović Ovčariček P, Campenni A, Treglia G, Deandreis D. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists. Eur J Nucl Med Mol Imaging. 2021;48(6):1719–1723. doi:10.1007/s00259-021-05316-0
   PubMed Web of Science ®Google Scholar
• Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601–615. doi:10.1038/s41591-021-01283-z
   PubMed Web of Science ®Google Scholar
• Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603
   PubMed Web of Science ®Google Scholar
• Amenta EM, Spallone A, Rodriguez-Barradas MC, et al. Postacute COVID-19: an Overview and Approach to Classification. Open Forum Infect Dis. 2020;7(12):ofaa509. doi:10.1093/ofid/ofaa509
   PubMed Web of Science ®Google Scholar
• Murray T. Unpacking “long COVID”. CMAJ. 2021;193(9):E318–E319. doi:10.1503/cmaj.1095923
   PubMed Web of Science ®Google Scholar
• Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. doi:10.1038/s41591-020-0968-3
   PubMed Web of Science ®Google Scholar
• Lui DTW, Lee CH, Chow WS, et al. Long COVID in Patients With Mild to Moderate Disease: do Thyroid Function and Autoimmunity Play a Role?. Endocr Pract. 2021;27(9):894–902. DOI:10.1016/j.eprac.2021.06.016
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Fragkou PC, Karofylakis E, et al. Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study. J Neurol Neurosurg Psychiatry. 2021:jnnp-2021-326587. doi:10.1136/jnnp-2021-326587
   Web of Science ®Google Scholar
• De Jongh F, Jobsis A, Elte J. Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur J Endocrinol. 2001;144(3):221–226. doi:10.1530/eje.0.1440221
   PubMed Web of Science ®Google Scholar
• Wei L, Sun S, Xu C, et al. Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol. 2007;38(1):95–102. doi:10.1016/j.humpath.2006.06.011
   PubMed Web of Science ®Google Scholar
• Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf). 2005;63(2):197–202. doi:10.1111/j.1365-2265.2005.02325.x
   PubMed Web of Science ®Google Scholar
• Chrousos GP, Kaltsas G. Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what? Clin Endocrinol (Oxf). 2005;63(4):363–365. doi:10.1111/j.1365-2265.2005.02361.x
   PubMed Web of Science ®Google Scholar
• Aguilera G. The Hypothalamic–Pituitary–Adrenal Axis and Neuroendocrine Responses to Stress, Handbook of Neuroendocrinology. Academic Press; 2012:175–196. doi:10.1016/B978-0-12-375097-6.10008-3
   Google Scholar
• Wang W, Ye YX, Yao H. Evaluation and observation of serum thyroid hormone and parathyroid hormone in patients with severe acute respiratory syndrome. J Chi Antitub Asso. 2003;25:232–234.
   Google Scholar
• Wei L, Sun S, Zhang J, et al. Endocrine cells of the adenohypophysis in severe acute respiratory syndrome (SARS). Biochem Cell Biol. 2010;88(4):723–730. doi:10.1139/O10-022
   PubMedGoogle Scholar
• Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816–825. doi:10.1016/S2213-8587(15)00225-9
   PubMed Web of Science ®Google Scholar
• Van den Berghe G. Non-thyroidal illness in the ICU: a syndrome with different faces. Thyroid. 2014;24(10):1456–1465. doi:10.1089/thy.2014.0201
   PubMed Web of Science ®Google Scholar
• Zou R, Wu C, Zhang S, et al. Euthyroid Sick Syndrome in Patients With COVID-19. Front Endocrinol (Lausanne). 2020;11:566439. doi:10.3389/fendo.2020.566439
   PubMed Web of Science ®Google Scholar
• Bartalena L, Bogazzi F, Brogioni S, Grasso L, Martino E. Role of cytokines in the pathogenesis of the euthyroid sick syndrome. Eur J Endocrinol. 1998;138(6):603–614. doi:10.1530/eje.0.1380603
   PubMed Web of Science ®Google Scholar
• Wajner SM, Maia AL. New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne). 2012;3:8. doi:10.3389/fendo.2012.00008
   PubMedGoogle Scholar
• Chen M, Zhou W, Xu W. Thyroid Function Analysis in 50 Patients with COVID-19: a Retrospective Study. Thyroid. 2021;31(1):8–11. doi:10.1089/thy.2020.0363
   PubMed Web of Science ®Google Scholar
• Muller I, Cannavaro D, Dazzi D, et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020;8(9):739–741. doi:10.1016/S2213-8587(20)30266-7
   PubMed Web of Science ®Google Scholar
• Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021;44(5):1031–1040. doi:10.1007/s40618-020-01460-w
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lin F, Tu W, et al. Thyroid dysfunction may be associated with poor outcomes in patients with COVID-19. Mol Cell Endocrinol. 2021;521:111097. doi:10.1016/j.mce.2020.111097
   PubMed Web of Science ®Google Scholar
• Khoo B, Tan T, Clarke SA, et al. Thyroid function before, during and after COVID-19. J Clin Endocrinol Metab. 2021;106(2):e803–e811. doi:10.1210/clinem/dgaa830
   PubMed Web of Science ®Google Scholar
• van Gerwen M, Alsen M, Little C, et al. Outcomes of Patients With Hypothyroidism and COVID-19: a Retrospective Cohort Study. Front Endocrinol (Lausanne). 2020;11:565. doi:10.3389/fendo.2020.00565
   PubMed Web of Science ®Google Scholar
• Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368–370. doi:10.1016/j.jmii.2020.03.005
   PubMedGoogle Scholar
• Lania A, Sandri MT, Cellini M, Mirani M, Lavezzi E, Mazziotti G. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020;183(4):381–387. doi:10.1530/EJE-20-0335
   PubMed Web of Science ®Google Scholar
• Tee LY, Hajanto S, Rosario BH. COVID-19 complicated by Hashimoto’s thyroiditis. Singapore Med J. 2020. doi:10.11622/smedj.2020106
   Web of Science ®Google Scholar
• Tabassom A, Edens MA. De Quervain Thyroiditis. StatPearls; 2020.
   Google Scholar
• Alzahrani AS, Ceresini G, Aldasouqi SA. Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool. Endocr Pract. 2012;18(4):567–578. doi:10.4158/EP11170.RA
   PubMed Web of Science ®Google Scholar
• Ippolito S, Dentali F, Tanda ML. SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case report. J Endocrinol Invest. 2020;43(8):1171–1172. doi:10.1007/s40618-020-01312-7
   PubMed Web of Science ®Google Scholar
• Kalra P, Kumar KM, Kallur KG, Vadyanathan V, Nadig M, Shankar M. Demographic data of thyroiditis from a south Indian city. Indian J Endocrinol Metab. 2015;19(2):300–302. doi:10.4103/2230-8210.149326
   PubMedGoogle Scholar
• Sweeney LB, Stewart C, Gaitonde DY. Thyroiditis: an integrated approach. Am Fam Phys. 2014;90:389–396.
   PubMed Web of Science ®Google Scholar
• Brancatella A, Ricci D, Viola N, Sgrò D, Santini F, Latrofa F. Subacute Thyroiditis After Sars-COV-2 Infection. J Clin Endocrinol Metab. 2020;105(7):dgaa276. doi:10.1210/clinem/dgaa276
   PubMed Web of Science ®Google Scholar
• Asfuroglu Kalkan E, Ates I. A case of subacute thyroiditis associated with Covid-19 infection. J Endocrinol Invest. 2020;43(8):1173–1174. doi:10.1007/s40618-020-01316-3
   PubMed Web of Science ®Google Scholar
• Brancatella A, Ricci D, Cappellani D, et al. Is Subacute Thyroiditis an Underestimated Manifestation of SARS-CoV-2 Infection? Insights From a Case Series. J Clin Endocrinol Metab. 2020;105(10):dgaa537. doi:10.1210/clinem/dgaa537
   PubMed Web of Science ®Google Scholar
• Ruggeri RM, Campennì A, Siracusa M, Frazzetto G, Gullo D. Subacute thyroiditis in a patient infected with SARS-COV-2: an endocrine complication linked to the COVID-19 pandemic. Hormones. 2021;20(1):219–221. doi:10.1007/s42000-020-00230-w
   PubMedGoogle Scholar
• Mattar SAM, Koh SJQ, Rama Chandran S, Cherng BPZ. Subacute thyroiditis associated with COVID-19. BMJ Case Rep. 2020;13(8):e237336. doi:10.1136/bcr-2020-237336
   PubMedGoogle Scholar
• Guven M. Subacute Thyroiditis in the Course of Coronavirus Disease 2019: a Case Report. J Endocrinol Metab. 2020;10:110–112. doi:10.14740/jem678
   Web of Science ®Google Scholar
• Campos-Barrera E, Alvarez-Cisneros T, Davalos-Fuentes M. Subacute Thyroiditis Associated with COVID-19. Case Rep Endocrinol. 2020;2020:8891539. doi:10.1155/2020/8891539
   PubMed Web of Science ®Google Scholar
• San Juan MDJ, Florencio MQV, Joven MH. SUBACUTE THYROIDITIS IN A PATIENT WITH CORONAVIRUS DISEASE 2019. AACE Clin Case Rep. 2020;6(6):e361–e364. doi:10.4158/ACCR-2020-0524
   PubMedGoogle Scholar
• Ruano R, Zorzano-Martinez M, Campos A, Rius F, Hernández M. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr. 2020. doi:10.1016/j.endinu.2020.09.002
   Web of Science ®Google Scholar
• Chong WH, Shkolnik B, Saha B, Beegle S. Subacute Thyroiditis in the Setting of Coronavirus Disease 2019. Am J Med Sci. 2021;361(3):400–402. doi:10.1016/j.amjms.2020.09.011
   PubMed Web of Science ®Google Scholar
• Chakraborty U, Ghosh S, Chandra A, Ray AK. Subacute thyroiditis as a presenting manifestation of COVID-19: a report of an exceedingly rare clinical entity. BMJ Case Rep. 2020;13(12):e239953. doi:10.1136/bcr-2020-239953
   PubMedGoogle Scholar
• Mehmood MA, Bapna M, Arshad M. A Case of Post-COVID-19 Subacute Thyroiditis. Cureus. 2020;12(12):e12301. doi:10.7759/cureus.12301
   PubMed Web of Science ®Google Scholar
• Khatri A, Charlap E, Kim A. Subacute Thyroiditis from COVID-19 Infection: a Case Report and Review of Literature. Eur Thyroid J. 2021;9(6):324–328. doi:10.1159/000511872
   PubMed Web of Science ®Google Scholar
• Davoodi L, Oladi Z, Jafarpour H, Zakariaei Z, Soleymani E, Razavi A. A 33-year-old man with COVID-19 presented with subacute thyroiditis: a rare case report and literature review. New Microbes New Infect. 2021;41:100871. doi:10.1016/j.nmni.2021.100871
   PubMed Web of Science ®Google Scholar
• Sohrabpour S, Heidari F, Karimi E, Ansari R, Tajdini A, Heidari F. Subacute Thyroiditis in COVID-19 Patients. Eur Thyroid J. 2021;9(6):321–323. doi:10.1159/000511707
   PubMed Web of Science ®Google Scholar
• Ghosh R, Dubey S, Sarkar A, et al. Antithyroid arthritis syndrome in a case of post-COVID-19 subacute thyroiditis. Diabetes Metab Syndr. 2021;15(3):683–686. doi:10.1016/j.dsx.2021.03.015
   PubMed Web of Science ®Google Scholar
• Mathews SE, Castellanos-Diaz J, Srihari A, et al. Subacute Thyroiditis and Heart Failure in a Patient Presenting With COVID-19. J Investig Med High Impact Case Rep. 2021;9:23247096211009412. doi:10.1177/23247096211009412
   Web of Science ®Google Scholar
• Abreu R, Miguel R, Saieg M. Subacute (De Quervain) thyroiditis during the COVID-19 pandemic. Cancer Cytopathol. 2021. doi:10.1002/cncy.22449
   PubMed Web of Science ®Google Scholar
• Seyed Resuli A, Bezgal M. Subacute Thyroiditis in COVID-19 Patients. Ear Nose Throat J. 2021;1455613211012114. doi:10.1177/01455613211012114
   Web of Science ®Google Scholar
• de la Higuera López-frías M, Perdomo CM, Galofré JC. Subacute thyroiditis following COVID-19 infection. Rev Clin Esp. 2021;221(6):370–372. doi:10.1016/j.rceng.2021.01.002
   Web of Science ®Google Scholar
• Tjønnfjord E, Moe RB, Ghanima W, Aballi S. Subacute thyroiditis after COVID-19. Tidsskr nor Laegeforen. 2021;141(10). doi:10.4045/tidsskr.21.0169
   Web of Science ®Google Scholar
• Feghali K, Atallah J, Norman C. Manifestations of thyroid disease post COVID-19 illness: report of Hashimoto thyroiditis, Graves’ disease, and subacute thyroiditis. J Clin Transl Endocrinol Case Rep. 2021;22:100094. doi:10.1016/j.jecr.2021.100094
   PubMedGoogle Scholar
• Sato D, Nishiguchi S, Tanaka E. Successful Management of Subacute Thyroiditis Following SARS-CoV-2 Infection: a Case Report. Intern Med. 2021. doi:10.2169/internalmedicine.7913-21
   Web of Science ®Google Scholar
• Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves’ disease after COVID-19. J Endocrinol Invest. 2020;43(10):1527–1528. doi:10.1007/s40618-020-01366-7
   PubMed Web of Science ®Google Scholar
• Diniz GP, Senger N, Carneiro-Ramos MS, Santos RA, Barreto-Chaves ML. Cardiac ACE2/angiotensin 1-7/Mas receptor axis is activated in thyroid hormone-induced cardiac hypertrophy. Ther Adv Cardiovasc Dis. 2016;10(4):192–202. doi:10.1177/1753944715623228
   PubMedGoogle Scholar
• Jiménez-Blanco S, Pla-Peris B, Marazuela M. COVID-19: a cause of recurrent Graves’ hyperthyroidism? J Endocrinol Invest. 2021;44(2):387–388. doi:10.1007/s40618-020-01440-0
   PubMed Web of Science ®Google Scholar
• Harris A, Al Mushref M. Graves’ Thyrotoxicosis Following SARS-CoV-2 Infection. AACE Clin Case Rep. 2021;7(1):14–16. doi:10.1016/j.aace.2020.12.005
   PubMedGoogle Scholar
• Lanzolla G, Marcocci C, Marinò M. Graves’ disease and Graves’ orbitopathy following COVID-19. J Endocrinol Invest. 2021;1–2. doi:10.1007/s40618-021-01576-7
   Web of Science ®Google Scholar
• Allam MM, El-Zawawy HT, Ahmed SM, Aly Abdelhamid M. Thyroid disease and covid-19 infection: case series. Clin Case Rep. 2021;9(6):e04225. doi:10.1002/ccr3.4225
   PubMed Web of Science ®Google Scholar
• Qureshi NK, Bansal SK. Autoimmune Thyroid Disease and Psoriasis Vulgaris after COVID-19 in a Male Teenager. Case Rep Pediatr. 2021;2021:7584729. doi:10.1155/2021/7584729
   PubMed Web of Science ®Google Scholar
• Montebello A. Recurrent Graves’ disease post SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244714. doi:10.1136/bcr-2021-244714
   PubMedGoogle Scholar
• Prummel MF, Strieder T, Wiersinga WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol. 2004;150(5):605–618. doi:10.1530/eje.0.1500605
   PubMed Web of Science ®Google Scholar
• Salvi M, Girasole G, Pedrazzoni M, et al. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves’ disease. J Clin Endocrinol Metab. 1996;81(8):2976–2979. doi:10.1210/jcem.81.8.8768861
   PubMed Web of Science ®Google Scholar
• Murugan AK, Alzahrani AS. SARS-CoV-2 plays a pivotal role in inducing hyperthyroidism of Graves’ disease. Endocrine. 2021;73(2):243–254. doi:10.1007/s12020-021-02770-6
   PubMed Web of Science ®Google Scholar
• Pastor S, Molina Á Sr, De Celis E. Thyrotoxic Crisis and COVID-19 Infection: an Extraordinary Case and Literature Review. Cureus. 2020;12(11):e11305. doi:10.7759/cureus.11305
   PubMed Web of Science ®Google Scholar
• Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda ML. Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic. J Endocrinol Invest. 2020;43(8):1149–1151. doi:10.1007/s40618-020-01293-7
   PubMed Web of Science ®Google Scholar
• Knack RS, Hanada T, Knack RS, Mayr K. Hashimoto’s thyroiditis following SARS-CoV-2 infection. BMJ Case Rep. 2021;14(8):e244909. doi:10.1136/bcr-2021-244909
   PubMedGoogle Scholar
• Varol AC, Hatice U, Gorgun S. COVID-19 and Hashimoto’s Disease. Rev Assoc Med Bras. 2021;67(5):640. doi:10.1590/1806-9282.20210242
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc2007575
   PubMed Web of Science ®Google Scholar
• Zulfiqar AA, Lorenzo-Villalba N, Hassler P, Andrès E. Immune thrombocytopenic purpura in a patient with COVID-19. N Engl J Med. 2020;382(18):e43. doi:10.1056/NEJMc2010472
   PubMed Web of Science ®Google Scholar
• Lazarian G, Quinquenel A, Bellal M, et al. Autoimmune haemolytic anaemia associated with COVID-19 infection. Br J Haematol. 2020;190(1):29–31. doi:10.1111/bjh.16794
   PubMed Web of Science ®Google Scholar
• Toscano G, Palmerini F, Ravaglia S, et al. Guillain-Barré Syndrome associated with SARSCoV-2. N Engl J Med. 2020;382(26):2574–2576. doi:10.1056/NEJMc2009191
   PubMed Web of Science ®Google Scholar
• Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Marchant D, Dou Y, Luo H, et al. Bosentan enhances viral load via endothelin-1 receptor type-A-mediated p38 mitogen-activated protein kinase activation while improving cardiac function during coxsackievirus-induced myocarditis. Circ Res. 2009;104(6):813–821. doi:10.1161/CIRCRESAHA.108.191171
   PubMed Web of Science ®Google Scholar
• Pantos C, Mourouzis I. Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair. Heart Fail Rev. 2015;20(3):273–282. doi:10.1007/s10741-014-9465-4
   PubMed Web of Science ®Google Scholar
• Sato R, Ariyoshi N, Hasegawa D, et al. Effects of inotropes on the mortality in patients with septic shock. J Intensive Care Med. 2021;36(2):211–219. doi:10.1177/0885066619892218
   PubMed Web of Science ®Google Scholar
• Padhi R, Kabi S, Panda BN, Jagati S. Prognostic significance of nonthyroidal illness syndrome in critically ill adult patients with sepsis. Int J Crit Illn Inj Sci. 2018;8(3):165–172. doi:10.4103/IJCIIS.IJCIIS_29_17
   PubMedGoogle Scholar
• Rajagopalan V, Gorecki M, Costello C, Schultz E, Zhang Y, Gerdes AM. Cardioprotection by triiodothyronine following caloric restriction via long noncoding RNAs. Biomed Pharmacother. 2020;131:110657. doi:10.1016/j.biopha.2020.110657
   PubMed Web of Science ®Google Scholar
• Pantos C, Tseti I, Mourouzis I. Use of triiodothyronine to treat critically ill COVID-19 patients: a new clinical trial. Crit Care. 2020;24(1):209. doi:10.1186/s13054-020-02934-2
   PubMedGoogle Scholar
• Pantos C, Kostopanagiotou G, Armaganidis A, Trikas A, Tseti I, Mourouzis I. Triiodothyronine for the treatment of critically ill patients with COVID-19 infection: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):573. doi:10.1186/s13063-020-04474-0
   PubMedGoogle Scholar
• Varedi M, Moattari A, Amirghofran Z, Karamizadeh Z, Feizi H. Effects of hypo- and hyperthyroid states on herpes simplex virus infectivity in the rat. Endocr Res. 2014;39(2):50–55. doi:10.3109/07435800.2013.808208
   PubMed Web of Science ®Google Scholar
• Salako O, Okunade K, Allsop M, et al. Upheaval in cancer care during the COVID-19 outbreak. Ecancermedicalscience. 2020;14:ed97. doi:10.3332/ecancer.2020.ed97
   PubMed Web of Science ®Google Scholar
• Chen AY, Shindo M. Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic. Head Neck. 2020;42(7):1418–1419. doi:10.1002/hed.26240
   PubMed Web of Science ®Google Scholar
• Alzahrani AS, Al Mourad M, Hafez K, et al. Diagnosis and Management of Hypothyroidism in Gulf Cooperation Council (GCC) Countries. Adv Ther. 2020;37(7):3097–3111. doi:10.1007/s12325-020-01382-2
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Wurfel MM, Himmelfarb J. Trajectory of Kidney Function: the Canary in Sepsis. Am J Respir Crit Care Med. 2020;202(9):1211–1212. doi:10.1164/rccm.202007-2627ED
   PubMed Web of Science ®Google Scholar
• Dworakowska D, Grossman AB. Thyroid disease in the time of COVID-19. Endocrine. 2020;68(3):471–474. doi:10.1007/s12020-020-02364-8
   PubMed Web of Science ®Google Scholar
• Prete A, Falcone M, Bottici V, et al. Thyroid cancer and COVID-19: experience at one single thyroid disease referral center. Endocrine. 2021;72(2):332–339. doi:10.1007/s12020-021-02650-z
   PubMed Web of Science ®Google Scholar
• Katopodis P, Kerslake R, Davies J, et al. COVID-19 and SARS-CoV-2 host cell entry mediators: expression profiling of TMRSS4 in health and disease. Int J Mol Med. 2021;47(4):64. doi:10.3892/ijmm.2021.4897
   PubMed Web of Science ®Google Scholar
• Smulever A, Abelleira E, Bueno F, Pitoia F. Thyroid cancer in the Era of COVID-19. Endocrine. 2020;70(1):1–5. doi:10.1007/s12020-020-02439-6
   PubMed Web of Science ®Google Scholar
• Raghavan D, Tan AR, Story ES, et al. Management changes for patients with endocrine-related cancers in the COVID-19 pandemic. Endocr Relat Cancer. 2020;27(9):R357–R374. doi:10.1530/ERC-20-0229
   PubMed Web of Science ®Google Scholar
• Vrachimis A, Iakovou I, Giannoula E, Giovanella L. ENDOCRINOLOGY IN THE TIME OF COVID-19: management of thyroid nodules and cancer. Eur J Endocrinol. 2020;183(1):G41–G48. doi:10.1530/EJE-20-0269
   PubMed Web of Science ®Google Scholar
• Casey RT, Valk GD, Schalin-Jäntti C, Grossman AB, Thakker RV. ENDOCRINOLOGY IN THE TIME OF COVID-19: clinical management of neuroendocrine neoplasms (NENs). Eur J Endocrinol. 2020;183(2):G79–G88. doi:10.1530/EJE-20-0424
   PubMed Web of Science ®Google Scholar
• Scappaticcio L, Pitoia F, Esposito K, Piccardo A, Trimboli P. Impact of COVID-19 on the thyroid gland: an update. Rev Endocr Metab Disord. 2020;1–13. doi:10.1007/s11154-020-09615-z
   PubMed Web of Science ®Google Scholar
• Mehta V, Goel S, Kabarriti R, et al. Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System. Cancer Discov. 2020;10(7):935–941. doi:10.1158/2159-8290.CD-20-0516
   PubMed Web of Science ®Google Scholar
• Kathuria-Prakash N, Mosaferi T, Xie M, et al. COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: a Multicenter Los Angeles Cohort Study. Endocr Pract. 2021;27(2):90–94. doi:10.1016/j.eprac.2020.12.013
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: a Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020;10(6):783–791. doi:10.1158/2159-8290.CD-20-0422
   PubMed Web of Science ®Google Scholar
• Falcone R, Grani G, Ramundo V, et al. Cancer Care During COVID-19 Era: the Quality of Life of Patients With Thyroid Malignancies. Front Oncol. 2020;10:1128. doi:10.3389/fonc.2020.01128
   PubMed Web of Science ®Google Scholar
• Klain M, Nappi C, Maurea S, et al. Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge. Eur J Nucl Med Mol Imaging. 2021;48(3):831–836. doi:10.1007/s00259-020-05041-0
   PubMed Web of Science ®Google Scholar
• Medas F, Ansaldo GL, Avenia N, et al.; Italian Society of Endocrine Surgery (SIUEC) Collaborative Group. Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study. Br J Surg. 2021;108(4):e166–e167. doi:10.1093/bjs/znab012
   PubMed Web of Science ®Google Scholar
• Givi B, Schiff BA, Chinn SB, et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg. 2020;146(6):579–584. doi:10.1001/jamaoto.2020.0780
   PubMed Web of Science ®Google Scholar
• Luo J, Rizvi H, Egger JV, Preeshagul IR, Wolchok JD, Hellmann MD. Impact of PD-1 Blockade on Severity of COVID-19 in Patients with Lung Cancers. Cancer Discov. 2020;10(8):1121–1128. doi:10.1158/2159-8290.CD-20-0596
   PubMed Web of Science ®Google Scholar
• Palladino R, Migliatico I, Sgariglia R, et al. Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic. Endocrine. 2021;71(1):20–25. doi:10.1007/s12020-020-02559-z
   PubMed Web of Science ®Google Scholar